News and Trends 13 Jul 2020
Sanofi Enlists Cell Therapy Firm Kiadis in €875M Immuno-Oncology Deal
…cells. Kiadis’ cell therapy complements Sanofi’s antibody drugs “because it provides a way to deliver cancer-attacking natural killer cells to patients,” Lahr said. The antibody drugs that Sanofi will combine…